Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
BMC Cancer ; 15: 30, 2015 Jan 31.
Artículo en Inglés | MEDLINE | ID: mdl-25636233

RESUMEN

BACKGROUND: Germline mutations in PALB2 have been identified in approximately 1% of familial breast cancer (BC) in several populations. Nevertheless its contribution in the South-American population is unknown. The goal of this study was to determine the prevalence of PALB2 mutations in the Chilean population. METHODS: 100 Chilean BRCA1/2-negatives familial BC cases were included for the PALB2 mutation analysis. We use conformational sensitive gel electrophoresis and direct sequencing. Using a case-control design, we studied the identified variants in 436 BC cases and 809 controls to evaluate their possible association with BC risk. RESULTS: No pathogenic mutations were detected. We identified three variants, the variant c.1861C > A not previously described was found in one of the 436 cases and none of the 809 controls. The bioinformatic analyses indicate that this variant probably is not pathogenic. PALB2 c.1676A > G (rs152451A/G) and c.2993C > T (rs45551636C/T) variants were significantly associated with increased BC risk only in cases with a strong family history of BC (OR = 1.9 [CI 95% 1.3-2.8] p < 0.01 and OR = 3.3 [CI 95% 1.4-7.3] p < 0.01, respectively). The rs152451A/G-rs45551636C/T composite genotype produce increase of the BC risk in cases with a strong family history of BC (OR = 3.6 [CI 95% 1.7-8.0] p = 0.003). The rs152451-G/rs45551636-C and rs152451-G/rs45551636-T haplotypes were associated with an increased BC risk only in cases with a strong family history of BC (OR = 1.6 [CI 95% 1.0-2.5] p = 0.05 and OR = 3.7 [CI 95% 1.8-7.5] p < 0.001, respectively). CONCLUSION: Our results suggest that PALB2 c.1676A > G and c.2993C > T play roles in BC risk in women with a strong family history of BC.


Asunto(s)
Predisposición Genética a la Enfermedad , Variación Genética , Proteínas Nucleares/genética , Proteínas Supresoras de Tumor/genética , Adulto , Edad de Inicio , Alelos , Neoplasias de la Mama/epidemiología , Neoplasias de la Mama/genética , Estudios de Casos y Controles , Chile/epidemiología , Biología Computacional , Análisis Mutacional de ADN , Proteína del Grupo de Complementación N de la Anemia de Fanconi , Femenino , Frecuencia de los Genes , Genotipo , Haplotipos , Humanos , Persona de Mediana Edad , Mutación , Vigilancia de la Población , Prevalencia , Riesgo , Adulto Joven
2.
Mol Biotechnol ; 60(3): 215-225, 2018 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-29442290

RESUMEN

Group B Streptococcus (GBS) is the leading cause of neonatal meningitis and a common pathogen in livestock and aquaculture industries around the world. Conjugate polysaccharide and protein-based vaccines are under development. The surface immunogenic protein (SIP) is a conserved protein in all GBS serotypes and has been shown to be a good target for vaccine development. The expression of recombinant proteins in Escherichia coli cells has been shown to be useful in the development of vaccines, and the protein purification is a factor affecting their immunogenicity. The response surface methodology (RSM) and Box-Behnken design can optimise the performance in the expression of recombinant proteins. However, the biological effect in mice immunised with an immunogenic protein that is optimised by RSM and purified by low-affinity chromatography is unknown. In this study, we used RSM for the optimisation of the expression of the rSIP, and we evaluated the SIP-specific humoral response and the property to decrease the GBS colonisation in the vaginal tract in female mice. It was observed by NI-NTA chromatography that the RSM increases the yield in the expression of rSIP, generating a better purification process. This improvement in rSIP purification suggests a better induction of IgG anti-SIP immune response and a positive effect in the decreased GBS intravaginal colonisation. The RSM applied to optimise the expression of recombinant proteins with immunogenic capacity is an interesting alternative in the evaluation of vaccines in preclinical phase, which could improve their immune response.


Asunto(s)
Proteínas Bacterianas/metabolismo , Escherichia coli/metabolismo , Inmunidad Humoral , Proteínas Recombinantes/metabolismo , Streptococcus agalactiae/metabolismo , Animales , Cromatografía Líquida de Alta Presión , Femenino , Inmunización , Espectrometría de Masas , Ratones Endogámicos C57BL , Reproducibilidad de los Resultados
3.
Biosystems ; 104(2-3): 118-26, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21277348

RESUMEN

The effect of the aluminum oxide on the thermal synthesis of the glycine-glutamic acid (Gly-Glu-(Gly-Glu)(n) polymer is described. The thermal synthesis in the molten state was carried out in the absence and presence of the oxide. In both cases, the vibrational spectra showed characteristic group frequencies corresponding predominantly to a Gly-Glu-(Gly-Glu)(n) sequence in the polymeric structure. The theoretical spectral data support the experimental proposed Gly-Glu-(Gly-Glu)(n) sequence for the polymer. The SEM-EDX characterization of the solid phase involved in the thermal synthesis showed that the aluminum oxide participates as a site for nucleation and growth of the polymer, explaining the increase of 25% efficiency in the presence of aluminum oxide. Electrophoresis data show shorter polypeptide chains in the presence of aluminum oxide.


Asunto(s)
Óxido de Aluminio/química , Dipéptidos/química , Péptidos/química , Secuencia de Aminoácidos , Electroforesis en Gel de Poliacrilamida , Microscopía Electrónica de Rastreo , Modelos Moleculares , Estructura Molecular , Peso Molecular , Estructura Secundaria de Proteína , Espectrometría por Rayos X , Espectroscopía Infrarroja por Transformada de Fourier , Espectrometría Raman
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA